Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

J Eugen-Olsen; O Andersen; A Linneberg; S Ladelund; W Hansen T; A Langkilde; Janne Petersen; T Pielak; N. L. Møller; J Jeppesen; S Lyngbæk; M Fenger; H Olsen M; K Borch-Johnsen; Torben Jørgensen; B Haugaard S; P. R.  Hildebrandt

doi:10.1111/j.1365-2796.2010.02252.x

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

J Eugen-Olsen, O Andersen, A Linneberg, S Ladelund, W Hansen T, A Langkilde, Janne Petersen, T Pielak, N. L. Møller, J Jeppesen, S Lyngbæk, M Fenger, H Olsen M, K Borch-Johnsen, Torben Jørgensen, B Haugaard S, P. R. Hildebrandt

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

330 Citationer (Scopus)

Abstract

Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.

Originalsprog	Engelsk
Tidsskrift	Journal of Internal Medicine
Vol/bind	268
Udgave nummer	3
Sider (fra-til)	296-308
Antal sider	13
ISSN	0954-6820
DOI	https://doi.org/10.1111/j.1365-2796.2010.02252.x
Status	Udgivet - 2010

Adgang til dokumentet

10.1111/j.1365-2796.2010.02252.x

Citationsformater

Eugen-Olsen, J., Andersen, O., Linneberg, A., Ladelund, S., Hansen T, W., Langkilde, A., Petersen, J., Pielak, T., Møller, N. L., Jeppesen, J., Lyngbæk, S., Fenger, M., Olsen M, H., Borch-Johnsen, K., Jørgensen, T., Haugaard S, B., & Hildebrandt, P. R. (2010). Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. Journal of Internal Medicine, 268(3), 296-308. https://doi.org/10.1111/j.1365-2796.2010.02252.x

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. / Eugen-Olsen, J; Andersen, O ; Linneberg, A; Ladelund, S; Hansen T, W; Langkilde, A; Petersen, Janne; Pielak, T; Møller, N. L.; Jeppesen, J; Lyngbæk, S; Fenger, M; Olsen M, H; Borch-Johnsen, K; Jørgensen, Torben; Haugaard S, B; Hildebrandt, P. R. .

I: Journal of Internal Medicine, Bind 268, Nr. 3, 2010, s. 296-308.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Eugen-Olsen, J, Andersen, O , Linneberg, A, Ladelund, S, Hansen T, W, Langkilde, A, Petersen, J, Pielak, T, Møller, NL, Jeppesen, J, Lyngbæk, S, Fenger, M, Olsen M, H, Borch-Johnsen, K, Jørgensen, T, Haugaard S, B & Hildebrandt, PR 2010, 'Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population', Journal of Internal Medicine, bind 268, nr. 3, s. 296-308. https://doi.org/10.1111/j.1365-2796.2010.02252.x

Eugen-Olsen, J ; Andersen, O ; Linneberg, A ; Ladelund, S ; Hansen T, W ; Langkilde, A ; Petersen, Janne ; Pielak, T ; Møller, N. L. ; Jeppesen, J ; Lyngbæk, S ; Fenger, M ; Olsen M, H ; Borch-Johnsen, K ; Jørgensen, Torben ; Haugaard S, B ; Hildebrandt, P. R. . / Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. I: Journal of Internal Medicine. 2010 ; Bind 268, Nr. 3. s. 296-308.

@article{e42aac368c014591837e8d090ad38194,

title = "Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population",

abstract = "Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.",

author = "J Eugen-Olsen and O Andersen and A Linneberg and S Ladelund and {Hansen T}, W and A Langkilde and Janne Petersen and T Pielak and M{\o}ller, {N. L.} and J Jeppesen and S Lyngb{\ae}k and M Fenger and {Olsen M}, H and K Borch-Johnsen and Torben J{\o}rgensen and {Haugaard S}, B and Hildebrandt, {P. R.}",

year = "2010",

doi = "10.1111/j.1365-2796.2010.02252.x",

language = "English",

volume = "268",

pages = "296--308",

journal = "Acta Medica Scandinavica",

issn = "0955-7873",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

AU - Eugen-Olsen, J

AU - Andersen, O

AU - Linneberg, A

AU - Ladelund, S

AU - Hansen T, W

AU - Langkilde, A

AU - Petersen, Janne

AU - Pielak, T

AU - Møller, N. L.

AU - Jeppesen, J

AU - Lyngbæk, S

AU - Fenger, M

AU - Olsen M, H

AU - Borch-Johnsen, K

AU - Jørgensen, Torben

AU - Haugaard S, B

AU - Hildebrandt, P. R.

PY - 2010

Y1 - 2010

N2 - Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.

AB - Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.

U2 - 10.1111/j.1365-2796.2010.02252.x

DO - 10.1111/j.1365-2796.2010.02252.x

M3 - Journal article

C2 - 20561148

VL - 268

SP - 296

EP - 308

JO - Acta Medica Scandinavica

JF - Acta Medica Scandinavica

SN - 0955-7873

IS - 3

ER -